Terrence W. Norchi - 06 Jul 2022 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)

Signature
/s/ Terrence Norchi
Issuer symbol
ARTHQ
Transactions as of
06 Jul 2022
Net transactions value
+$24,000
Form type
4
Filing time
08 Jul 2022, 16:55:15 UTC
Previous filing
01 Oct 2021
Next filing
10 Nov 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARTH Common Stock Award +72,435 +2.5% 2,981,512 06 Jul 2022 Direct F1
holding ARTH Common Stock 10,000,000 06 Jul 2022 By Twelve Pins Partners, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTH Senior Secured Convertible Notes Award $24,000 $24,000 06 Jul 2022 Common Stock 525,164 Direct F1, F3
transaction ARTH Warrants Award +482,897 482,897 06 Jul 2022 Common Stock 482,897 $0.0497 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock, senior secured convertible notes (the "Notes") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the "Offering"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.
F2 The Reporting Person disclaims beneficial ownership of the securities held by Twelve Pins Partners, LLC except to the extent of his pecuniary interest therein.
F3 The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations.
F4 Conversion of the warrants is subject to certain beneficial ownership limitations.